文献速递心脑血管急症儿科与产科急症重症综合管理与镇静镇痛

儿童创伤性脑损伤与微血管血脑屏障病理

Pediatric Traumatic Brain Injury and Microvascular Blood-Brain Barrier Pathology.
PubMed 文献 · JAMA Netw Open · 2024-11-04
一句话结论尸检病例系列显示,儿童中重度TBI后脑肿胀多为弥漫双侧(83% vs 成人34%),血脑屏障破坏以毛细血管水平微血管病变为主。

该回顾性病例系列纳入1979年1月1日至2005年12月31日格拉斯哥TBI档案的尸检材料,比较儿童(3-18岁)与成人(≥19岁)单次中重度TBI后脑肿胀和血脑屏障破坏的神经病理证据。儿童81例、成人62例。儿童脑肿胀更常为弥漫双侧(64/81,83% vs 21/62,34%,P<.001)。血脑屏障破坏在两组均常见(儿童65/81,80% vs 成人57/62,91%,P=.06),但儿童以毛细血管水平微血管病变为主(平均84.7% vs 31.2%,P<.001)。作者认为这可能是儿童弥漫性脑肿胀的候选病理机制,需进一步研究。

要点

  • 儿童中重度TBI尸检中脑肿胀更常为弥漫双侧:儿童64/81(83%)vs 成人21/62(34%),P<.001。
  • 血脑屏障破坏在儿童(65/81,80%)与成人(57/62,91%)均常见,差异未达统计学显著(P=.06)。
  • 儿童血脑屏障破坏以毛细血管水平微血管病变为主:平均84.7% vs 成人31.2%,P<.001。
  • 成人血脑屏障破坏更多累及较大直径血管,提示年龄依赖的血管病理差异。
  • 作者认为儿童急性TBI的独特微血管病理可能是弥漫性脑肿胀的候选机制,需进一步研究。

适用人群与场景

  • 儿童(3-18岁)与成人(≥19岁)单次中度或重度急性TBI死亡病例的尸检脑组织材料。
  • 来源为格拉斯哥TBI档案,病例 accrual 时间为1979年1月1日至2005年12月31日。

研究设计与关键结果

  • 回顾性病例系列:儿童81例(平均[SD]年龄12.1[4.6]岁;男性50例[62%]),成人62例(平均[SD]年龄38.7[12.9]岁;男性35例[56%])。
  • 脑肿胀存在时,儿童更常为弥漫双侧:儿童64/81(83%)vs 成人21/62(34%),P<.001。
  • 血脑屏障破坏组织学证据:成人57/62(91%)vs 儿童65/81(80%),P=.06。
  • 儿童血脑屏障破坏以毛细血管水平微血管病变为主:平均[SD]84.7%[8.6%] vs 成人31.2%[7.7%],P<.001。
  • 成人血脑屏障破坏更多累及较大直径血管。

证据类型、等级与局限

  • 证据类型:回顾性病例系列(尸检材料实验室评估)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为儿童急性TBI的独特微血管病理可能是弥漫性脑肿胀的候选机制,需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Pediatric traumatic brain injury (TBI) is a major cause of morbidity and mortality, with an increased risk of catastrophic outcome compared with adult TBI, including diffuse brain swelling and so-called second impact syndrome. Nevertheless, the biological substrates driving adverse outcomes in pediatric TBI remain poorly described.

OBJECTIVE: To compare neuropathological evidence of brain swelling and blood-brain barrier (BBB) disruption after moderate or severe acute TBI in adult vs pediatric case material.

DESIGN, SETTING, AND PARTICIPANTS: In this retrospective case series, cases of pediatric (aged 3-18 years) and adult (aged ≥19 years) TBI were accrued from January 1, 1979, to December 31, 2005, and underwent laboratory-based assessment of autopsy material from the Glasgow TBI Archive. Data analysis was performed from January 2019 to January 2024.

EXPOSURES: Single moderate or severe TBI.

MAIN OUTCOMES AND MEASURES: Evaluation of representative brain tissue sections stained for markers of endothelia (CD34) and BBB integrity (fibrinogen and immunoglobin G).

RESULTS: Eighty-one pediatric patients (mean [SD] age, 12.1 [4.6] years; 50 [62%] male) and 62 adult patients (mean [SD] age, 38.7 [12.9] years; 35 [56%] male) were studied. At autopsy, when present, brain swelling was more often diffuse and bilateral among pediatric patients (64 of 81 cases [83%]) when compared with adult patients (21 of 62 [34%]) (P < .001). Histologic evidence of BBB disruption was common in material from both adult (57 of 62 [91%]) and pediatric (65 of 81 [80%]) (P = .06) patients. In pediatric patients, however, this was a predominantly microvascular, capillary-level pathology, which was a less common finding in adult case material (mean [SD], 84.7% [8.6%] vs 31.2% [7.7%]; P < .001).

CONCLUSIONS AND RELEVANCE: This autopsy case series of patients dying in the acute phase after single moderate or severe TBI provides neuropathological evidence of age-dependent differences in vascular pathology. Specifically, although BBB disruption in pediatric material was typically confined to microvascular, capillary-level vessels, in adult case material, BBB disruption more typically involved larger-diameter vessels. This observation of distinct microvascular pathology in pediatric acute TBI requires further investigation. In the meantime, this study presents an intriguing potential candidate pathology contributing to diffuse brain swelling in this age group.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Fullerton JL, Hay J, Bryant-Craig C, et al. Pediatric Traumatic Brain Injury and Microvascular Blood-Brain Barrier Pathology. JAMA Netw Open. 2024. PMID: 39585695. doi:10.1001/jamanetworkopen.2024.46767

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。